Floatz logo

145 assets in Metastatic Neoplasm

Therapeutic assets addressing Metastatic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Tegodor
Metastatic Neoplasm
Ruijin HospitalP2CCC (54)
Allogeneic Tumour Lysate
Metastatic Neoplasm
Elios Therapeutics, LLCP2CCC (53)
Catequentinib
Metastatic Neoplasm
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.P2CCC (53)
Ergotidine
Metastatic Neoplasm
Sahlgrenska University HospitalP2CCC (53)
Imsa101
Metastatic Neoplasm
University of Texas Southwestern Medical CenterP2CCC (53)
Leronlimab
Metastatic Neoplasm
CytoDyn, Inc.P2CCC (53)
Lobaplatin
Metastatic Neoplasm
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP2CCC (53)
Luvometinib
Metastatic Neoplasm
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.P2CCC (53)
Nab-Sirolimus
Metastatic Neoplasm
Aadi Bioscience, Inc.P2CCC (53)
Teonanacatl
Metastatic Neoplasm
University Health Network, TorontoP2CCC (53)
Tumor Lysate, Particle Only Vaccine
Metastatic Neoplasm
Elios Therapeutics, LLCP2CCC (53)
Rifaldazine
Metastatic Neoplasm
Jiangsu vcare pharmaceutical technology co., LTDP1CCC (52)
Immunoglobulin G1, Anti-(Human Programmed Death-Ligand 1) (Human Monoclonal Sti-3031 .Gamma.1-Chain), Disulfide With Human Monoclonal Sti-3031 .Lambda.-Chain, Dimer
Metastatic Neoplasm
ImmuneOncia Therapeutics Inc.P2CCC (51)
Lomustine
Metastatic Neoplasm
Actuate Therapeutics Inc.P2CCC (51)
Trastuzumab Deruxtecan
Metastatic Neoplasm
UNICANCERP2CCC (51)
Elraglusib
Metastatic Neoplasm
Actuate Therapeutics Inc.P2CCC (49)
AS01b
Metastatic Neoplasm
Universitair Ziekenhuis BrusselP1/2CCC (48)
Eb-Dnk101 Dual-Targeting Car-Nk Cells
Metastatic Neoplasm
Beijing BiotechP1/2CCC (48)
Eb-Dnk102 Dual-Targeting Car-Nk Cells
Metastatic Neoplasm
Beijing BiotechP1/2CCC (48)
Garsorasib
Metastatic Neoplasm
Suzhou Genhouse Bio Co., Ltd.P1/2CCC (48)
gh21
Metastatic Neoplasm
Suzhou Genhouse Bio Co., Ltd.P1/2CCC (48)
hlx301
Metastatic Neoplasm
Shanghai Henlius BiotechP1/2CCC (48)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
Metastatic Neoplasm
Jiangsu HengRui Medicine Co., Ltd.P1/2CCC (48)
Max-40279-01: /
Metastatic Neoplasm
Maxinovel Pty., Ltd.P1/2CCC (48)
Autologous Dual-Target Car-T Cells Selected From The Predefined Target Library.
Metastatic Neoplasm
Beijing BiotechP1/2CC (47)
hb1801
Metastatic Neoplasm
Shanghai Runshi Pharmaceutical Technology Co., LtdP1/2CC (47)
ibi3014
Metastatic Neoplasm
Innovent Biologics (Suzhou) Co. Ltd.P1/2CC (47)
Icasp9M28Z T Cell Infusions
Metastatic Neoplasm
Memorial Sloan Kettering Cancer CenterP1/2CC (47)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Metastatic Neoplasm
Memorial Sloan Kettering Cancer CenterP1/2CC (47)
ism3412
Metastatic Neoplasm
InSilico Medicine Hong Kong LimitedP1/2CC (47)
Lorlatinib
Metastatic Neoplasm
Memorial Sloan Kettering Cancer CenterP1/2CC (47)
Nadravaleucel
Metastatic Neoplasm
NKGen Biotech, Inc.P1/2CC (47)
PE0105
Metastatic Neoplasm
Shanghai HyaMab Biotech Co.,Ltd.P1/2CC (47)
Sarilumab
Metastatic Neoplasm
University of Southern CaliforniaP1/2CC (47)
sg001
Metastatic Neoplasm
Shanghai Runshi Pharmaceutical Technology Co., LtdP1/2CC (47)
tst003
Metastatic Neoplasm
Suzhou Transcenta Therapeutics Co., Ltd.P1/2CC (47)
vc004
Metastatic Neoplasm
Jiangsu vcare pharmaceutical technology co., LTDP1CC (47)
fl115
Metastatic Neoplasm
Suzhou Forlong Biotechnology Co., LtdP1CC (46)
hy-0102
Metastatic Neoplasm
Shanghai HyaMab Biotech Co.,Ltd.P1CC (46)
Alintegimod
Metastatic Neoplasm
7 Hills Pharma, LLCP1/2CC (45)
Bicalutamide
Metastatic Neoplasm
Icahn School of Medicine at Mount SinaiP1/2CC (45)
Ifinatamab Deruxtecan
Metastatic Neoplasm
Merck Sharp & Dohme LLCP1/2CC (45)
mk-5684
Metastatic Neoplasm
Merck Sharp & Dohme LLCP1/2CC (45)
Xrd-0394
Metastatic Neoplasm
XRad Therapeutics IncP1CC (44)
177lu-ctr-fapi
Metastatic Neoplasm
Lanzhou University Second HospitalEarly P1CC (43)
[177Lu]Lu-TEFAPI-06
Metastatic Neoplasm
Lanzhou University Second HospitalEarly P1CC (43)
225Ac-MTI-201
Metastatic Neoplasm
Modulation Therapeutics, Inc.P1CC (43)
4.7 microci 225ac-mti-201
Metastatic Neoplasm
Modulation Therapeutics, Inc.P1CC (43)
998 microci of 225ac-mti-201
Metastatic Neoplasm
Modulation Therapeutics, Inc.P1CC (43)
Amg 410
Metastatic Neoplasm
AmgenP1CC (43)
Showing 51 to 100 of 145 assets
PreviousPage 2 of 3Next